Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-28T00:53:51.180Z Has data issue: false hasContentIssue false
  • English
  • Français

The 2017 Seventh World Congress of Pediatric Cardiology & Cardiac Surgery: week in review – adults with CHD*

Published online by Cambridge University Press:  29 December 2017

Jolien W. Roos-Hesselink ,
Daniel Tobler  and
Carole Warnes
Jolien W. Roos-Hesselink*
Affiliation:
Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands
Daniel Tobler
Affiliation:
Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland
Carole Warnes
Affiliation:
Department of Cardiology, Mayo Clinic, Rochester, United States of America
*
Correspondence to: J. W. Roos-Hesselink, MD, PhD, Department of Cardiology Ba583a, Erasmus MC, Thoraxcenter, PO Box 2040, 3000 CA Rotterdam, The Netherlands. Tel: +3 110 703 2432; Fax: +3 110 703 5498; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

For the first time in 2017 adults with CHD was included in the World Congress of Pediatric Cardiology & Cardiac Surgery. With growing numbers and more complex patients reaching adulthood, there is a growing need for more attention to this subspecialty. Although survival is excellent and now over 90% of patients reach adulthood, many have residual problems and complications. Heart failure and arrhythmias are most commonly encountered. Life-expectancy is nearly normal for mild lesions, but remains reduced in moderate-complex lesions and re-interventions are often needed. As most patients want to live a normal life, sports participation and pregnancy become very important issues. Finally, although innovative treatments are being developed, including for end-stage heart failure, we have to refine strategies for optimal care, including during the end-stage lives of our patients. This article provides an overview of a selection of topics in the field of adults with CHD presented during the 2017 Seventh World Congress of Pediatric Cardiology & Cardiac Surgery (WCPCCS) in Barcelona.

Keywords

Adult CHDpregnancyheart failurearrhythmiasoutcome
Type
Original Articles
Information
Cardiology in the Young , Volume 27 , Special Issue 10: Proceedings of the 2017 7th World Congress of Pediatric Cardiology & Cardiac Surgery (WCPCCS 2017) Barcelona, Spain July 16–21, 2017 , December 2017 , pp. 2025 - 2028
Copyright
© Cambridge University Press 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

*

Presented at the 2017 Seventh World Congress of Pediatric Cardiology & Cardiac Surgery (WCPCCS 2017), Barcelona, Spain, July 16–21, 2017. Presented Friday, July 21, 2017.

References

1. Diller, GP, Kempny, A, Alonso-Gonzalez, R, et al. Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre. Circulation 2015; 132: 2118–2125.CrossRefGoogle Scholar
2. Tutarel, O, Kempny, A, Alonso-Gonzalez, R, et al. Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality. Eur Heart J 2014; 35: 725–732.CrossRefGoogle ScholarPubMed
3. Niwa, K, Perloff, JK, Bhuta, SM, et al. Structural abnormalities of great arterial walls in congenital heart disease: light and electron microscopic analyses. Circulation 2001; 103: 393–400.CrossRefGoogle ScholarPubMed
4. Tan, JL, Davlouros, PA, McCarthy, KP, Gatzoulis, MA, Ho, SY. Intrinsic histological abnormalities of aortic root and ascending aorta in tetralogy of Fallot: evidence of causative mechanism for aortic dilatation and aortopathy. Circulation 2005; 112: 961–968.CrossRefGoogle ScholarPubMed
5. Niwa, K, Siu, SC, Webb, GD, Gatzoulis, MA. Progressive aortic root dilatation in adults late after repair of tetralogy of Fallot. Circulation 2002; 106: 1374–1378.CrossRefGoogle ScholarPubMed
6. Mizuno, A, Niwa, K, Matsuo, K, et al. Survey of reoperation indications in tetralogy of Fallot in Japan. Circ J 2013; 77: 2942–2947.CrossRefGoogle ScholarPubMed
7. Gersony, DR, McClaughlin, MA, Jin, Z, Gersony, WM. The effect of beta-blocker therapy on clinical outcome in patients with Marfan’s syndrome: a meta-analysis. Int J Cardiol 2007; 114: 303–308.CrossRefGoogle Scholar
8. Engelfriet, P, Mulder, B. Is there benefit of beta-blocking agents in the treatment of patients with the Marfan syndrome? Int J Cardiol 2007; 114: 300–302.CrossRefGoogle ScholarPubMed
9. Ladouceur, M, Fermanian, C, Lupoglazoff, JM, et al. Effect of beta-blockade on ascending aortic dilatation in children with the Marfan syndrome. Am J Cardiol 2007; 99: 406–409.CrossRefGoogle ScholarPubMed
10. Lacro, RV, Dietz, HC, Sleeper, LA, et al. Atenolol versus losartan in children and young adults with Marfan’s syndrome. N Engl J Med 2014; 371: 2061–2071.CrossRefGoogle Scholar
11. de Groot, NM, Atary, JZ, Blom, NA, Schalij, MJ. Long-term outcome after ablative therapy of postoperative atrial tachyarrhythmia in patients with congenital heart disease and characteristics of atrial tachyarrhythmia recurrences. Circ Arrhythm Electrophysiol 2010; 3: 148–154.CrossRefGoogle ScholarPubMed
12. Vojtovic, P, Kucera, F, Kubus, P, et al. Acute right ventricular resynchronization improves haemodynamics in children after surgical repair of tetralogy of Fallot. Europace 2017; Mar 23. doi: 10.1093/europace/euw414. [Epub ahead of print].Google Scholar
13. Baggen, VJ, van den Bosch, AE, Eindhoven, JA, et al. Prognostic value of N-terminal pro-B-type natriuretic peptide, troponin-T, and growth-differentiation factor 15 in adult congenital heart disease. Circulation 2017; 135: 264–279.CrossRefGoogle ScholarPubMed
14. Eindhoven, JA, van den Bosch, AE, Jansen, PR, Boersma, E, Roos-Hesselink, JW. The usefulness of brain natriuretic peptide in complex congenital heart disease: a systematic review. J Am Coll Cardiol 2012; 60: 2140–2149.CrossRefGoogle ScholarPubMed
15. Babu-Narayan, SV, Uebing, A, Davlouros, PA, et al. Randomised trial of ramipril in repaired tetralogy of Fallot and pulmonary regurgitation: the APPROPRIATE study (Ace inhibitors for Potential PRevention Of the deleterious effects of Pulmonary Regurgitation In Adults with repaired TEtralogy of Fallot). Int J Cardiol 2012; 154: 299–305.CrossRefGoogle ScholarPubMed
16. Norozi, K, Bahlmann, J, Raab, B, et al. A prospective, randomized, double-blind, placebo controlled trial of beta-blockade in patients who have undergone surgical correction of tetralogy of Fallot. Cardiol Young 2007; 17: 372–379.CrossRefGoogle ScholarPubMed
17. VanderPluym, CJ, Cedars, A, Eghtesady, P, et al. Outcomes following implantation of mechanical circulatory support in adults with congenital heart disease: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). J Heart Lung Transplant 2017; Mar 7. pii: S1053-2498(17)31682-0. doi: 10.1016/j.healun.2017.03.005. [Epub ahead of print].Google ScholarPubMed
18. Greutmann, M, Tobler, D, Kovacs, AH, et al. Increasing mortality burden among adults with complex congenital heart disease. Congenit Heart Dis 2015; 10: 117–127.CrossRefGoogle ScholarPubMed
19. Burchill, LJ. Heart transplantation in adult congenital heart disease. Heart 2016; 102: 1871–1877.CrossRefGoogle ScholarPubMed